Patents by Inventor Jennifer Badiang

Jennifer Badiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolopyridinyl pyridine
    Publication number: 20070287721
    Abstract: The present invention provides compounds of formula (I): pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
    Type: Application
    Filed: October 4, 2006
    Publication date: December 13, 2007
    Inventors: F. Leslie Boyd, Stanley Chamberlain, Mui Cheung, Kristjan Gudmundsson, Philip Harris, Brian Johns, David Jung, Michael Peel, Jennifer Badiang, Connie Sexton
  • Pyrazolopyridines, process for their preparation and use as therapeutic compounds
    Patent number: 7109209
    Abstract: The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
    Type: Grant
    Filed: October 7, 2005
    Date of Patent: September 19, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Michael John Alberti, Stanley D. Chamberlain, Mui Cheung, Kristjan Gudmundsson, Philip Anthony Harris, Brian A. Johns, David Kendall Jung, Michael Robert Peel, Jennifer Badiang Stanford
  • Pyralopyridines, process for their preparation and use as therapeutic compounds
    Patent number: 7034030
    Abstract: The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: April 25, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Michael John Alberti, Stanley D. Chamberlain, Mui Cheung, Kristjan Gudmundsson, Philip Anthony Harris, Brian A. Johns, David Kendall Jung, Michael Robert Peel, Jennifer Badiang Stanford
  • Pyrazolopyridazine derivatves
    Publication number: 20050090507
    Abstract: Fused pyradazine derivatives, which are useful as CDK inhibitors are described herein. The described invention also includes methods of making such fused pyradazines derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Application
    Filed: December 11, 2002
    Publication date: April 28, 2005
    Inventors: Jennifer Badiang, Scott Dickerson, Philip Harris, David Jung, Michael Peel, Michael Reno, Tara Rheault, Kirk Stevens, Francis Tavares, James Veal
  • Theraopeutic compounds
    Publication number: 20050049259
    Abstract: The present invention provides compounds of formula (I): pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
    Type: Application
    Filed: November 26, 2001
    Publication date: March 3, 2005
    Inventors: F Boyd, Stanley Chamberlain, Mui Cheung, Kristjan Gudmundsson, Philip Harris, Brian Johns, David Jung, Michael Peel, Jennifer Badiang, Connie Sexton
  • Fused pyrazole derivatives bieng protein kinase inhibitors
    Publication number: 20040053942
    Abstract: Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, (R2, and R4 are various substituent groups, are protein kinase inhibitors.
    Type: Application
    Filed: July 7, 2003
    Publication date: March 18, 2004
    Inventors: Michael John Alberti, Ian Baldwin, Mui Cheung, Stuart Cockerill, Philip Harris, David Jung, Gregory Peckham, Michael Peel, Jennifer Badiang, Kirk Stevens, James Veal
  • Formamide compounds as therapeutic agents
    Patent number: 6329400
    Abstract: A family of compounds having the general structural formula where W is a reverse hydroxamic acid group, and R1, R2, R3, R4, R5 and R6 are as described in the specification, or a pharmaceutically acceptable salt, solvate, biohydrolyzable ester, biohydrolyzable amide, affinity reagent, or prodrug thereof.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: December 11, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Robert Carl Andrews, Marc Werner Andersen, Dulce Garrido Bubacz, Joseph Howing Chan, David John Cowan, Michael David Gaul, Daryl Lynn McDougald, David Lee Musso, Michael Howard Rabinowitz, Jennifer Badiang Stanford, Robert William Wiethe
  • Formamide compounds as therapeutic agents
    Patent number: 6191150
    Abstract: A family of compounds having the general structural formula where W is a reverse hydroxamic acid group, and R1, R2, R3, R4, R5 and R6 are as described in the specification, or a pharmaceutically acceptable salt, solvate, biohydrolyzable ester, biohydrolyzable amide, affinity reagent, or prodrug thereof.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: February 20, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Robert Carl Andrews, Marc Werner Andersen, Dulce Garrido Bubacz, Joseph Howing Chan, David John Cowan, Michael David Gaul, Daryl Lynn McDougald, David Lee Musso, Michael Howard Rabinowitz, Jennifer Badiang Stanford, Robert William Wiethe